Explore our labs
To drive new discoveries, our labs conduct a diverse portfolio of research, from basic science to clinical interventions, drawing from the world's largest set of data on suicide mortality and leading numerous collaborations worldwide.
Bilder Neurodevelopmental Lab
Dr. Deborah Bilder studies prenatal risk factors and co-occurring mental health concerns in individuals with autism, intellectual disabilities, and single-gene disorders impacting neurodevelopment, including phenylketonuria.
Diagnostic Neuroimaging Lab
Dr. Deborah Yurgelun-Todd and Dr. Perry Renshaw focus on applying magnetic resonance methods to develop improved diagnostic paradigms and to guide the development of treatment strategies
Diagnostic Neuroimaging Lab: Women’s Health
Dr. Erin McGlade uses neuroimaging methodology as a framework for conceptualizing and studying sex-based brain differences and psychiatric symptom manifestation throughout the developmental lifespan.
Medical Machine Intelligence Lab
Dr. Warren Pettine investigates the use of innovating genomic foundation models to uncover complicated polygenetic interactions with a focus on predicting the progression of Alzheimer’s dementia.
Mickey Lab
Dr. Brian Mickey studies brain stimulation and brain imaging to better understand the circuits that underlie neuropsychiatric illnesses.
Monson Lab
Dr. Eric T. Monson investigates the intersection of psychological trauma and severe outcomes, including suicide, through the clinical and genetic evaluation of children and adolescents.
Motor and Cognition Lab
Dr. Vincent Koppelmans studies the causes and neural correlates of motor dysfunction in Alzheimer's disease and depression, and explores how these findings can be leveraged for classification and prediction models.
Multimodal Approaches to Pathogenic Personality and Emotions Development Lab
Dr. Erin Kaufman uses the developmental psychopathology perspective as a framework for conceptualizing and studying self-inflicted injury, borderline personality disorder, and suicide.
Psychiatric Genomics Lab
Dr. Anna Docherty studies genetic risk and resilience across medical and psychiatric disorders, and in the context of severe outcomes like psychosis and suicide.
Rapaport and Kinkead Research Group
Dr. Mark Rapaport and Dr. Becky Kinkead explores the interface between psychiatry and complementary and integrative medicine.
Research on preventable death outcomes and women's health lab
Dr. Emily DiBlasi explores gender-specific risk factors in preventable death outcomes and women's health across the lifespan, aiming to uncover the associated biological underpinnings.
University of Utah Psychedelic Science Initiative
Dr. Benjamin Lewis studies, develops, and implements evidence-based psychedelic medicine interventions to address patients suffering with difficult to treat conditions and advance the field of psychedelic medicine.
Utah Registry of Autism and Developmental Disabilities
The Utah Registry of Autism and Developmental Disabilities uses a passive, population-based system to determine the number and characteristics of persons in Utah with autism spectrum disorder and other developmental disabilities.